AstraZeneca Reportedly Eliminates 600 US Sales Positions To Fund Pipeline
The cuts, which affected staff marketing the asthma drugs Breztri and Airsupra, mark an early step in the company’s three-year cost-saving program, Bloomberg reported.
The cuts, which affected staff marketing the asthma drugs Breztri and Airsupra, mark an early step in the company’s three-year cost-saving program, Bloomberg reported.